UiPath Stock Analysis: First Annual Profit Meets "Agentic AI" Momentum

UiPath, Inc. (NYSE: PATH) reported solid fourth quarter and full-year fiscal 2026 results, highlighting steady revenue growth, expanding profitability, and continued momentum in enterprise automation and agentic AI. The company has reached a historic milestone, reporting its first full year of GAAP profitability.

UiPath stock AI analysis chart

Strong Q4 Results

For the fourth quarter ended January 31, 2026, UiPath generated revenue of $481 million, representing a 14% year-over-year increase. Annualized Renewal Run-rate (ARR), a key metric for subscription software businesses, reached $1.853 billion, up 11% from the previous year. Net new ARR during the quarter totaled $70 million, while the company maintained a dollar-based net retention rate of 107%, indicating that existing customers continue expanding their usage of the platform.

Profitability also improved meaningfully. UiPath posted GAAP operating income of $80 million, producing a 17% operating margin compared with 8% in the same quarter last year. On a non-GAAP basis, operating income reached $150 million with a 31% operating margin, compared with 32% in Q4 FY2025. Net income for the quarter came in at $104.5 million, or $0.19 per diluted share, while non-GAAP net income reached $164.3 million, equivalent to $0.30 per share. The company also generated strong cash flow, reporting $182 million in operating cash flow and non-GAAP adjusted free cash flow.

Fiscal 2026 Marks First Year of GAAP Profitability

For the full fiscal year 2026, UiPath delivered revenue of $1.611 billion, up 13% year-over-year. Notably, the company achieved full-year GAAP profitability for the first time in company history, posting GAAP operating income of $57 million compared with a loss in fiscal 2025. Non-GAAP operating income rose to $370 million, reflecting a margin of 23%, demonstrating more consistent execution and expanding operating leverage. GAAP net income was $282.3 million, or $0.52 per diluted share, while non-GAAP net income per share was $0.72.

Expanding AI Automation Platform and Industry Partnerships

Management emphasized that enterprise adoption of AI-driven automation is shifting from experimentation toward large-scale deployment. UiPath aims to position its platform as the execution layer for enterprise AI by combining deterministic automation, agentic AI capabilities, and orchestration tools designed for complex business processes.

During the quarter, the company continued expanding its ecosystem and product portfolio. UiPath launched new agentic AI solutions for healthcare organizations focused on medical record summarization and claims processing. It also announced the acquisition of WorkFusion, a specialist in AI agents for financial crime compliance, strengthening its industry offerings for banks and financial institutions. Additional partnerships and integrations with companies such as Veeva and Talkdesk further broaden the platform’s reach into financial services, life sciences, retail, and more industries.

Capital Allocation and Balance Sheet Strength

From a capital allocation perspective, UiPath completed its previously authorized $1 billion share repurchase program and announced a new $500 million buyback authorization. The company ended the fiscal year with $1.69 billion in cash, cash equivalents, and marketable securities, providing significant financial flexibility.

Fiscal 2027 Outlook

Looking ahead, UiPath expects steady growth in fiscal 2027:

Q1 FY2027 guidance

Revenue: $395 million – $400 million
ARR: $1.894 billion – $1.899 billion
Non-GAAP operating income: ~$80 million

Full-year FY2027 guidance

Revenue: $1.754 billion – $1.759 billion
ARR: $2.051 billion – $2.056 billion
Non-GAAP operating income: ~$415 million

Technical Analysis

Currently, $15 serves as the immediate resistance. A clean break and daily close above this level is required to signal that the market is pricing in the new profitability milestone. If the stock clears $15, the next significant resistance sits at $19. The stock’s near-term direction will largely depend on whether it can decisively break through a key technical resistance level.

However, failure to hold the current momentum could see the stock retreat to seek a floor. Strong historical support lies in the $8 to $10 range.